ADAsli Aybike Dogan

Asli Aybike Dogan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Asli Aybike Dogan has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Standalone single- and bi-layered human skin 3D models supported by recombinant silk feature native spatial organization

    by Savvini Gkouma, Nayanika Bhalla, Solène Frapard, Alexander Jönsson, Hakan Gürbüz, Asli Aybike Dogan, Stefania Giacomello, Martin Duvfa, Patrik L Ståhl, Mona Widhe, et al.

    Physiologically relevant human skin models that include key skin cell types can be used for in vitro drug testing, skin pathology studies, or clinical applications such as skin grafts. However, there is still no golden standard for such a model. We investigated the potential of a recombinant functionalized spider silk protein, FN-silk, for the construction of a dermal, an epidermal, and a bilayered skin equivalent (BSE). Specifically, two formats of FN-silk (i.e. 3D network and nanomembrane) were evaluated. The 3D network was used as an elastic ECM-like support for the dermis, and the thin, permeable nanomembrane was used as a basement membrane to support the epidermal epithelium. Immunofluorescence microscopy and spatially resolved transcriptomics analysis demonstrated the secretion of key ECM components and the formation of microvascular-like structures. Furthermore, the epidermal layer exhibited clear stratification and the formation of a cornified layer, resulting in a tight physiologic epithelial barrier. Our findings indicate that the presented FN-silk-based skin models can be proposed as physiologically relevant standalone epidermal or dermal models, as well as a combined BSE.


  • Open Access

    Three-Dimensional (3D) systems provide a more realistic tool to model Parkinson’s Disease (PD) in vitro

    by Aslı DOGAN, Zehra Morcimen, Seyma Tasdemir, Sinem Turunc, Seda Vatansever, Aylin Sendemir

    Parkinson’s Disease (PD), which exhibits a rapidly developing pathology, is one of the most devastating neurodegenerative diseases. To understand its molecular and cellular mechanisms and to attain a truly effective treatment, it is essential to develop standard, rapid, and reliable in vitro testing platforms for diseases. Classical two-dimensional (2D) cell culture is the starting point for the study of PD diagnosis and treatment. However, 2D grown cells do not exhibit the physiological properties of native tissues and provide limited data for testing drugs in vitro and understanding the mechanisms of diseases. Therefore, realistic 3D models similar to human physiology are required. In this study, the 2D and 3D PD modeling potentials of two cell lines (SHSY5Y and PC12), which are frequently used in neural tissue engineering studies, were compared. PD models generated by SHSY5Y and PC12 cells were evaluated by lactate dehydrogenase (LDH), Live&Dead, immunofluorescence, and quantitative reverse transcription polymerase chain reaction (qRT-PCR) analyses. It was determined that PC12 cells had weaker adherence properties than SHSY5Y cells, and therefore, SHSY5Y cells had higher microtissue formation potential. PC12 cells completely lost their dopaminergic properties in 3D conditions, whereas 6-OHDA applied SHSY5Y microtissues showed PD markers related to neurotoxicity. A practical and useful 3D disease model reflecting the characteristics of PD with SHSY5Y cells is presented.

  • Open Access

    Surface Area of Graphene Governs Its Neurotoxicity

    by Şeyma Taşdemir, Zehra Gül Morçimen, Aslı Aybike Doğan, Cansu Görgün, Aylin Şendemir

    Due to their unique physicochemical properties, graphene and its derivatives are widely exploited for biomedical applications. It has been shown that graphene may exert different degrees of toxicity in in vivo or in vitro models when administered via different routes and penetrated through physiological barriers, subsequently being distributed within tissues or located within cells. In this study, in vitro neurotoxicity of graphene with different surface areas (150 and 750 m2/g) was examined on dopaminergic neuron model cells. SH-SY5Y cells were treated with graphene possessing two different surface areas (150 and 750 m2/g) in different concentrations between 400 and 3.125 μg/mL, and the cytotoxic and genotoxic effects were investigated. Both sizes of graphene have shown increased cell viability in decreasing concentrations. Cell damage increased with higher surface area. Lactate dehydrogenase (LDH) results have concluded that the viability loss of the cells is not through membrane damage. Neither of the two graphene types showed damage through lipid peroxidation (MDA) oxidative stress pathway. Glutathione (GSH) values increased within the first 24 and 48 h for both types of graphene. This increase suggests that graphene has an antioxidant effect on the SH-SY5Y model neurons. Comet analysis shows that graphene does not show genotoxicity on either surface area. Although there are many studies on graphene and its derivatives on their use with different cells in the literature, there are conflicting results in these studies, and most of the literature is focused on graphene oxide. Among these studies, no study examining the effect of graphene surface areas on the cell was found. Our study contributes to the literature in terms of examining the cytotoxic and genotoxic behavior of graphene with different surface areas.


  • 3D bioprinting: A powerful tool to leverage tissue engineering and microbial systems

    by Ecem Saygili, Asli Aybike Dogan-Gurbuz, Ozlem Yesil-Celiktas, Mohamed S. Draz


  • Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine

    by Hua Shen, Xiaoyi Huang, Jie Min, Shiguan Le, Qing Wang, Xi Wang, Asli Aybike Dogan, Xiangsheng Liu, Pengfei Zhang, Mohamed Shehata Draz, et al.

    The rapid development of nanotechnology has a great influence on the fields of biology, physiology, and medicine. Over recent years, nanoparticles have been widely presented as nanocarriers to help the delivery of gene, drugs, and other therapeutic agents with cellular targeting ability. Advances in the understanding of gene delivery and RNA interference (RNAi)-based therapy have brought increasing attention to understanding and tackling complex genetically related diseases, such as cancer, cardiovascular and pulmonary diseases, autoimmune diseases and infections. The combination of nanocarriers and DNA/RNA delivery may potentially improve their safety and therapeutic efficacy. However, there still exist many challenges before this approach can be practiced in the clinic. In this review, we provide a comprehensive summary on the types of nanoparticle systems used as nanocarriers, highlight the current use of nanocarriers in recombinant DNA and RNAi molecules delivery, and the current landscape of gene-based nanomedicine-ranging from diagnosis to therapeutics. Finally, we briefly discuss the biosafety concerns and limitations in the preclinical and clinical development of nanoparticle gene systems.


  • Open Access

    Improved Generation of Induced Pluripotent Stem Cells From Hair Derived Keratinocytes – A Tool to Study Neurodevelopmental Disorders as ADHD

    by Silvano Re, Asli Aybike Dogan, Dorit Ben-Shachar, Gregor Berger, Anna Maria Werling, Susanne Walitza, Edna Grünblatt

    In the last decade, there is an increasing application of induced pluripotent stem cells (iPSCs) for disease modeling. The iPSC technology enables the study of patient-specific neuronal cell lines in vitro to evaluate dysfunction at the cellular level and identify the responsible genetic factors. This approach might be particularly valuable for filling the gap of knowledge at the cellular and molecular levels underlying the pathophysiology of various neurodevelopmental and/or psychiatric disorders, such as attention-deficit hyperactivity disorder (ADHD). However, the invasiveness of skin biopsy or blood withdrawal might represent a major impediment in such protected population. Using hair derived keratinocytes as starting somatic cells circumvents this problem as sample collections can be performed non-invasively. Here we describe an improved, convenient, standardized and effective method to culture and reprogram hair derived keratinocytes from three healthy controls and one ADHD patient into iPSCs, which in turn will be used to generate differentiated neuronal cells. All the cell types were maintained in highly defined, serum-free conditions and showed expression of the respective key marker genes, assessed by both immunocytochemistry and qRT-PCR. The described in vitro personalized neuronal model has its advantage in modeling neurodevelopmental trajectories since it can recapitulate key processes of brain development at the cellular and molecular level and is intended to be used as for example studying ADHD etiopathology.